Exane Derivatives Acadia Healthcare Company, Inc. Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Acadia Healthcare Company, Inc. stock. As of the latest transaction made, Exane Derivatives holds 2 shares of ACHC stock, worth $81. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2
Previous 17
88.24%
Holding current value
$81
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ACHC
# of Institutions
346Shares Held
96.8MCall Options Held
474KPut Options Held
406K-
Wellington Management Group LLP Boston, MA11.7MShares$474 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.89MShares$361 Million0.01% of portfolio
-
Black Rock Inc. New York, NY8.21MShares$334 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.12MShares$249 Million0.23% of portfolio
-
Viking Global Investors LP3.7MShares$150 Million0.91% of portfolio
About Acadia Healthcare Company, Inc.
- Ticker ACHC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 90,841,000
- Market Cap $3.69B
- Description
- Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company offers behavioral healthcare services to its patients in various settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics. As of March 31, 2022...